You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 210 No. 5, November 3, 1969 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

LSD and Chromosomes

A Controlled Experiment

Joe-Hin Tjio, PhD; Walter N. Pahnke, MD, PhD; Albert A. Kurland, MD

JAMA. 1969;210(5):849-856.


Abstract

The chromosomes of lymphocytes were studied in 32 patients before and after they took lysergic acid diethylamide (LSD) as part of double-blind, controlled research of the effects of the drug in psychotherapy and in five black-market LSD users who volunteered to take pure LSD in a research setting. Statistical analysis revealed no significant difference between the before- and after-LSD chromosomal aberration rates. In addition, a post-LSD study of eight normal subjects who had received LSD in previous research experiments was also performed with the same cytogenetic methods. The results of these experiments consistently supported the conclusion that at this time there is no definite evidence that pure LSD damages chromosomes of human lymphocytes in vivo as studied from 72-hour cultures.



Author Affiliations

From the National Institute of Arthritis and Metabolic Disease, National Institutes of Health, Bethesda, Md (Dr. Tjio); the Johns Hopkins University School of Medicine, Baltimore (Dr. Pahnke); and the Maryland Psychiatric Research Center, Baltimore (Drs. Pahnke and Kurland).


Footnotes

Read in part before the American College of Neuropsychopharmacology, San Juan, Puerto Rico, Dec 20, 1968.

Reprint requests to Maryland Psychiatric Research Center, Box 3235, Baltimore 21228 (Dr. Pahnke).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Human hallucinogen research: guidelines for safety
Johnson et al.
J Psychopharmacol 2008;22:603-620.
ABSTRACT  

Chromosomal Aberration Rates and Intravenously Given Diazepam: A Negative Study
White et al.
JAMA 1974;230:414-417.
ABSTRACT  

Silver-Russell Dwarfism and Cystic Fibrosis in a Twin: Endocrine, Chromosomal, Dermatoglyphic, and Craniofacial Studies
Taussig et al.
Arch Pediatr Adolesc Med 1973;125:495-503.
ABSTRACT  

Human Chromosomes and Opiates
Falek et al.
Arch Gen Psychiatry 1972;27:511-515.
ABSTRACT  

Chromosomal Analyses of Bone Marrow and Peripheral Blood in Subjects With a History of Illicit Drug Use
Amarose and Schuster
Arch Gen Psychiatry 1971;25:181-186.
ABSTRACT  

LSD and Genetic Damage
Dishotsky et al.
Science 1971;172:431-440.
ABSTRACT  

Chromosomal Aberrations in Users of Psychoactive Drugs
Gilmour et al.
Arch Gen Psychiatry 1971;24:268-272.
ABSTRACT  

Chromosome Examinations in Patients on Lithium Carbonate
Jarvik et al.
Arch Gen Psychiatry 1971;24:166-168.
ABSTRACT  

The Experimental Use of Psychedelic (LSD) Psychotherapy
Pahnke et al.
JAMA 1970;212:1856-1863.
ABSTRACT  

Effect of LSD on Human Pregnancy
McGlothlin et al.
JAMA 1970;212:1483-1487.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1969 American Medical Association. All Rights Reserved.